Replies to post #130305 on Biotech Values

[DewDiligence]

DEB025 is one of the few HCV drugs in mid-stage development that really and truly has a chance to be a meaningful player, IMO. See #msg-56880596 for the reason.

Also see #msg-61671677 and #msg-56835202 for prior data reports.